Discover 1,506 paid clinical trials in Loveland, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,506
Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories
for
Bile Duct Adenocarcinoma, Bile Duct Carcinoma
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 21+
Code: NCT07120295
Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Aurora CO, Salt Lake City UT, Amarillo TX,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Aurora CO, Colorado Springs CO, Rock Springs WY,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase 3, Recruiting
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Preventing Maternal Mood, Anxiety, and Trauma Symptoms After Cesarean Delivery
for
Anxiety in Pregnancy,
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: Female
Age: 0+
Code: NCT06949813
Recruiting
A Pilot RCT to Improve Cognitive Processing Speed in Acute SCI
for
Spinal Cord Injuries, Cognitive Dysfunction,
Location: Englewood CO, East Hanover NJ
Sponsor: Kessler Foundation
Sex: All
Age: 18 - 59
Code: NCT06238492
Recruiting
Featured
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
for
Breast Reconstruction
Location: Aurora CO, St Louis MO, Orange CA, Los Angeles CA,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06575192
Phase 3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer